NMIC Bulletin Vol. 29 No. 2 Management of Menopause
Share
Print
22 March, 2023
Management of Menopause
Assessment of menopausal women should consider factors including patient’s age, symptoms and impact on quality of life, and risk for cardiovascular disease and osteoporosis
In general, the benefits of hormone replacement therapy (HRT) outweigh the risks for most women with menopausal symptoms aged <60 years or within 10 years of menopause
Transdermal oestrogen administration is associated with a lower risk of venous thromboembolism and stroke than oral administration
Women should be informed that HRT is not a contraceptive method
